BioAid collects and organizes biological samples and associated data to accelerate medical-scientific research and for diagnostic purposes.
BioAid represents extremely diverse collections of tissue specimens. We organize these in a systematic way for use by others. These are generally cryopreserved at hospital pathology departments following their usual mode of sampling by invasive medical procedures, thereby representing residual “bioptic material”. These samples are associated with detailed information on the nature of the underlying disease for which these were sampled. Following patient consent, hospital information systems may allow further annotation of a given bioptate with longitudinal follow-up clinical records, response to treatment and eventually final disease outcome. A specific form of tissue banks is represented by formalin-fixed paraffin embedded (FFPE) specimen collections.
Biobanking has been conducted in tandem with many clinical trials. The major aim of clinical trial related biobanking is to identify disease/trial-associated biomarkers.
Personalized Medicine or ‘P4 Medicine’ involves the following characteristics:
“Personalization” which reflects the individual “digital genome”.
“Predictiveness” which is due to the ability to predict the risk of certain diseases based on “personal genome” information in combination with lifestyle data, age, sex, occupation etc.
“Preventiveness” that is based on individualized risk prediction.
This requires an active “participation” of the individual concerned in proactively maintaining their health.
Such a paradigm shift in medical practice will empower individuals to undertake informed decisions about their health future.
BioAid has a strong foundation to ensure privacy protection. To protect your privacy, the information shared does not include names, addresses, or dates of birth. Donations are matched to information in the patient registry in a way that ensures privacy.
Inclusion of patients and patient organizations as partners in the research effort, especially in the areas of communication, advocacy and recruitment (e.g. information to potential donors, preparation of informed consent forms).
Consideration of the experience, knowledge and expertise of patients, families and careers.
Listening to patients’ voices/expectations on research needs from their experience from participating in biobanking as donors.
Regular, general and reasonable feedback to patients regarding use, sharing and transfer of samples.
Full professor, Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Certified Chemist, Kossuth Lajos University, PhD in Biological Sciences, Doctor of Biological Sciences (D.Sci.), Member of the Presidential Council of the Hungarian Biochemical Society.
1975, 1978 Research Award of the Hungarian Academy of Sciences, 1999 Albert Szent-Györgyi Award, 2004 Arnold Ipolyi Award, 2007 Béla Tankó Award, 2008 Széchenyi Award, 2011 Leo Szilard Award, 2015 Order of Merit of Hungary (Officer)
1991-2000 member of the Hungarian Research Fund (panel for physiology and biochemistry), 2000-2004 chairman of the section for molecular biology at the Hungarian Research Fund, 2007-2010 member of the Life Sciences Committee of the Hungarian Research Fund, 1994-1997, 2001-2004 elected representative of the Hungarian Academy of Sciences, 1999- president of the Doctoral Committee for Life Sciences at the University of Debrecen, 1999-2010 president of the Research and Innovation Committee of Medical and Health Science Center, University of Debrecen, 2007-2103 head of the Committee for Bólyai Fellowship in Biology at the Hungarian Academy of Sciences, 2007-2013 member of the Committee of D. Sci. at the Hungarian Academy of Sciences, 2008- member of the Committee of Research Units sponsored by the Hungarian Academy of Sciences, 2013- President of the Debrecen Committee of the Hungarian Academy of Sciences
Fields of interest:
Molecular biology, signal transfer, regulation of protein kinases& phosphatases, metabolic disorders (diabetes), Scientometric data: Scientific publications: 157 (in English), Books/Book chapters: 6, Cumulative impact factor: 480.271, Citations: 3955, Hirsch Index: 34, Number of graduated Ph.D. students: 10
Link for list of publications:
Headed the Tissue Engineering Research of the Plastic and Hand Surgery Department at the University Hospital Freiburg, Germany. Member of numerous scientific and professional societies, as well as co-founder and initial co-ordinator of the Valley Tissue Engineering Centre in Germany. Responsible for developing and implementing new cell based technologies and products in the field of human tissue repair, replacement and regeneration. Her research activities have been focusing on the development of cell based therapies for the treatment of degenerative diseases in the field of orthopedics and maxillofacial surgery. Lives in Zürich, Switzerland.
Hungary’s largest independent biopharmaceutical company. Mr. Duda is also Founder and President of the Hungarian Biotechnology Association, Co-Founder and Chairman of Aquincum Technology Incubator, and Co-Founder and Senior Consultant of Qualinnova Consulting. He has been acting as CEO since 1999, and as a genuine entrepreneur, he has founded or co-founded 20 companies, including a corporate finance consulting company focused on high-tech Hungarian start-ups, and Hungary’s largest online second-hand book store. He was Vice President of the American Chamber of Commerce in Hungary, and President of the Junior Achievement Foundation Hungary. Mr. Duda was a member of the Research and Technology Innovation Council, the Board of Trustees of the Bay Zoltán Foundation for Applied Research, and works on the board of the Hungarian Association for Innovation. As an Associate Professor at the University of Szeged, he holds courses on the business aspects of the biotech industry. He is also a regular contributor to newspapers, periodicals and other publications, and frequently holds presentations on biotechnology and entrepreneurship at conferences, trainings and other public events.
Founder and Former Director of the Semmelweis University Centre for Grants and Innovation, Associate Professor for innovation management at Semmelweis University, studed at Semmelweis University Budapest Hungary, Imperial College London UK and Harvard University Cambridge USA. Former national representative, Programme Committee member of the EU Seventh Framework Programme and member of the EU Innovative Medicines Initiative Member States Contact Group. Chief Executive of the Medipole European Competitiveness Pole Project for the City of Budapest and the Central Region of Hungary. Former member of the National Innovation Advisory Council. Founding member of the European Health Management Association’s Transitional Countries Network for Senior Health Managers and Policy Makers. Founder and member of the Board of the Hungarian Association for Telemedicine and E-Health. Member of the Presidium of the Hungarian Association for Innovation.